www.peacefulmeds.com was cited for unlawfully selling unapproved and misbranded drugs over the internet, including opioids, benzodiazepines, and injectable semaglutide products, in violation of sections 301(a), 301(d), 301(k), 503(b), and 505(a) of the Federal Food, Drug, and Cosmetic Act. The company's compliance failures included introducing these drugs into interstate commerce without FDA approval and without proper labeling, creating significant public health risks given the ongoing opioid epidemic and the potential for abuse and serious harm from misused benzodiazepines and improperly administered injectable products. The FDA emphasized particular concern about the easy internet availability of controlled substances and injectable drugs that lack proper medical oversight and quality assurance.